These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19495495)

  • 1. [Relationship between research funding in the Spanish National Health System and the burden of disease].
    Catalá López F; Alvarez Martín E; Gènova Maleras R; Morant Ginestar C
    Rev Esp Salud Publica; 2009; 83(1):137-51. PubMed ID: 19495495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship between disease burden and research funding through the Health Research Foundation in Spain].
    Gómez-García T; Moreno-Casbas T; González-María E; Fuentelsaz-Gallego C
    Enferm Clin; 2014; 24(4):219-32. PubMed ID: 24819151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To what extent is health and medical research funding associated with the burden of disease in Australia?
    Aoun S; Pennebaker D; Pascal R
    Aust N Z J Public Health; 2004 Feb; 28(1):80-6. PubMed ID: 15108752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NSFC health research funding and burden of disease in China.
    Xu G; Zhang Z; Lv Q; Li Y; Ye R; Xiong Y; Jiang Y; Liu X
    PLoS One; 2014; 9(11):e111458. PubMed ID: 25369330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation Between National Institutes of Health Funding for Pediatric Research and Pediatric Disease Burden in the US.
    Rees CA; Monuteaux MC; Herdell V; Fleegler EW; Bourgeois FT
    JAMA Pediatr; 2021 Dec; 175(12):1236-1243. PubMed ID: 34515752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The national burden of cerebrovascular diseases in Spain: a population-based study using disability-adjusted life years.
    Catalá-López F; Fernández de Larrea-Baz N; Morant-Ginestar C; Álvarez-Martín E; Díaz-Guzmán J; Gènova-Maleras R
    Med Clin (Barc); 2015 Apr; 144(8):353-9. PubMed ID: 24863563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme research funding and UK burden of disease.
    Chinnery F; Bashevoy G; Blatch-Jones A; Douet L; Puddicombe S; Raftery J
    Trials; 2018 Feb; 19(1):87. PubMed ID: 29394905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applying DALY to assessing national health insurance performance: the relationship between the national health insurance expenditures and the burden of disease measures in Iran.
    Russel M
    Int J Health Plann Manage; 2005; 20(2):89-98. PubMed ID: 15991456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public funding for medical research in relation to the burden of disease caused by cardiovascular diseases and neoplasms in Germany.
    Krone M; Dufner V; Wagner M; Gelbrich G; Ertl G; Heuschmann PU
    Clin Res Cardiol; 2018 Sep; 107(9):737-744. PubMed ID: 29654436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relation between funding by the National Institutes of Health and the burden of disease.
    Gross CP; Anderson GF; Powe NR
    N Engl J Med; 1999 Jun; 340(24):1881-7. PubMed ID: 10369852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The disease burden of cardiovascular and circulatory diseases in China, 1990 and 2010].
    Liu J; Liu Y; Wang L; Yin P; Liu S; You J; Zeng X; Zhou M
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Apr; 49(4):315-20. PubMed ID: 26081539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited alignment of publicly competitive disease funding with disease burden in Japan.
    Nomura S; Yoneoka D; Tanaka S; Makuuchi R; Sakamoto H; Ishizuka A; Nakamura H; Kubota A; Shibuya K
    PLoS One; 2020; 15(2):e0228542. PubMed ID: 32040510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Spanish Burden of Disease 2010: Neurological, mental and substance use disorders.
    Lara E; Garin N; Ferrari AJ; Tyrovolas S; Olaya B; Sànchez-Riera L; Whiteford HA; Haro JM
    Rev Psiquiatr Salud Ment; 2015; 8(4):207-17. PubMed ID: 25435363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of cancer burden and research spending reveals discrepancies in the distribution of research funding.
    Carter AJ; Nguyen CN
    BMC Public Health; 2012 Jul; 12():526. PubMed ID: 22800364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing cutaneous research funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases with 2010 Global Burden of Disease results.
    Karimkhani C; Boyers LN; Margolis DJ; Naghavi M; Hay RJ; Williams HC; Naldi L; Coffeng LE; Weinstock MA; Dunnick CA; Pederson H; Vos T; Murray CJ; Dellavalle RP
    PLoS One; 2014; 9(7):e102122. PubMed ID: 25003335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the burden of disease and research funding by the Medical Research Council of Canada and the National Institutes of Health. A cross-sectional study.
    Lamarre-Cliche M; Castilloux AM; LeLorier J
    Clin Invest Med; 2001 Apr; 24(2):83-9. PubMed ID: 11368150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring static and dynamic relationships between burden of disease and research funding in the United States.
    Nimgaonkar A; Mughal AY; Heimer H; Nimgaonkar V; Greenstein D; Wright A
    Health Res Policy Syst; 2022 Jun; 20(1):60. PubMed ID: 35659236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing cutaneous research funded by the US National Institutes of Health (NIH) with the US skin disease burden.
    Hagstrom EL; Patel S; Karimkhani C; Boyers LN; Williams HC; Hay RJ; Weinstock MA; Armstrong AW; Dunnick CA; Margolis DJ; Dellavalle RP
    J Am Acad Dermatol; 2015 Sep; 73(3):383-91.e1. PubMed ID: 26051697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational allocation of Australia's research dollars: does the distribution of NHMRC funding by National Health Priority Area reflect actual disease burden?
    Mitchell RJ; McClure RJ; Olivier J; Watson WL
    Med J Aust; 2009 Dec 7-21; 191(11-12):648-52. PubMed ID: 20028294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissonant health transition in the states of Mexico, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
    Gómez-Dantés H; Fullman N; Lamadrid-Figueroa H; Cahuana-Hurtado L; Darney B; Avila-Burgos L; Correa-Rotter R; Rivera JA; Barquera S; González-Pier E; Aburto-Soto T; de Castro EF; Barrientos-Gutiérrez T; Basto-Abreu AC; Batis C; Borges G; Campos-Nonato I; Campuzano-Rincón JC; de Jesús Cantoral-Preciado A; Contreras-Manzano AG; Cuevas-Nasu L; de la Cruz-Gongora VV; Diaz-Ortega JL; de Lourdes García-García M; Garcia-Guerra A; de Cossío TG; González-Castell LD; Heredia-Pi I; Hijar-Medina MC; Jauregui A; Jimenez-Corona A; Lopez-Olmedo N; Magis-Rodríguez C; Medina-Garcia C; Medina-Mora ME; Mejia-Rodriguez F; Montañez JC; Montero P; Montoya A; Moreno-Banda GL; Pedroza-Tobías A; Pérez-Padilla R; Quezada AD; Richardson-López-Collada VL; Riojas-Rodríguez H; Ríos Blancas MJ; Razo-Garcia C; Mendoza MP; Sánchez-Pimienta TG; Sánchez-Romero LM; Schilmann A; Servan-Mori E; Shamah-Levy T; Téllez-Rojo MM; Texcalac-Sangrador JL; Wang H; Vos T; Forouzanfar MH; Naghavi M; Lopez AD; Murray CJ; Lozano R
    Lancet; 2016 Nov; 388(10058):2386-2402. PubMed ID: 27720260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.